Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recormon QoL and Efficacy in Anemic Cancer Patients
NCT00776425Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Primary completion
- Nov 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, open-label trial of epoetin beta in anemia (2 arms), sponsored by Roche. Primary endpoints: Percentage of Participants Who Achieved a Clinical Response, Quality of Life of Anemic Participants Using Short Form 36 (SF-36) Questionnaire and 2 more. Started Jan 2007; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00776425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776425.